Alps Advisors Inc Fate Therapeutics Inc Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$21.04 - $36.06 $91,944 - $157,582	-4,370 Reduced 7.62%	52,950 $1.19 Million
Q2 2022 Aug 11, 2022	BUY	$17.78 - $42.39 $1.02 Million - $2.43 Million	57,320 New	57,320 $1.42 Million
Q2 2021 Aug 11, 2021	SELL	$67.25 - $92.52 $8.79 Million - $12.1 Million	-130,688 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$72.16 - $117.4 $456,051 - $741,968	6,320 Added 5.08%	130,688 $10.8 Million
Q4 2020 Feb 03, 2021	BUY	$38.09 - $100.95 $518,823 - $1.38 Million	13,621 Added 12.3%	124,368 $11.3 Million
Q3 2020 Nov 04, 2020	BUY	$30.41 - $40.5 $144,994 - $193,104	4,768 Added 4.5%	110,747 $4.43 Million
Q2 2020 Aug 05, 2020	SELL	$20.21 - $35.23 $635,685 - $1.11 Million	-31,454 Reduced 22.89%	105,979 $3.64 Million
Q1 2020 May 06, 2020	SELL	$17.28 - $31.88 $254,430 - $469,401	-14,724 Reduced 9.68%	137,433 $3.05 Million
Q4 2019 Feb 07, 2020	BUY	$13.39 - $20.73 $291,513 - $451,312	21,771 Added 16.7%	152,157 $2.98 Million
Q3 2019 Nov 04, 2019	SELL	$15.47 - $22.5 $93,562 - $136,080	-6,048 Reduced 4.43%	130,386 $2.03 Million
Q2 2019 Aug 07, 2019	SELL	$15.61 - $20.44 $302,896 - $396,617	-19,404 Reduced 12.45%	136,434 $2.77 Million
Q1 2019 May 01, 2019	BUY	$13.15 - $18.71 $88,565 - $126,011	6,735 Added 4.52%	155,838 $2.74 Million
Q4 2018 Feb 04, 2019	BUY	$11.48 - $16.98 $626,475 - $926,615	54,571 Added 57.73%	149,103 $1.91 Million
Q3 2018 Oct 25, 2018	BUY	$8.75 - $16.29 $155,907 - $290,255	17,818 Added 23.23%	94,532 $1.54 Million
Q2 2018 Aug 02, 2018	BUY	$9.16 - $13.48 $702,700 - $1.03 Million	76,714 New	76,714 $870,000

Others Institutions Holding FATE

# of Institutions

175

Shares Held

115M

Call Options Held

53.7K

Put Options Held

Redmile Group, LLC San Francisco, CA

13.2M
Shares

$29.2 Million
3.01% of portfolio
Vanguard Group Inc Valley Forge, PA

10.4M
Shares

$23.1 Million
0.0% of portfolio
Black Rock Inc. New York, NY

10.1M
Shares

$22.5 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

5.57M
Shares

$12.4 Million
0.72% of portfolio
State Street Corp Boston, MA

5.25M
Shares

$11.7 Million
0.0% of portfolio

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $215M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account